Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression

Eur J Immunol. 2005 Nov;35(11):3221-8. doi: 10.1002/eji.200535053.

Abstract

Nef expression is not required for HIV-1 replication and is highly targeted by CD8+ CTL, raising the question of why Nef expression is not lost in order to evade immunity in vivo. We explore whether MHC class I (MHC-I) down-regulation to evade CTL in general is a selective pressure maintaining Nef. HIV-1 with functional Nef (wild type, WT) is compared to virus containing a Nef point mutation (M20A) that selectively ablates MHC-I down-regulation. WT-infected cells are relatively resistant to cytolysis and less suppressed for viral replication by Gag- and RT-specific CTL compared to M20A. These viruses grow similarly in vitro in the absence of CTL, but the presence of Gag- or RT-specific CTL strongly favors WT overgrowth of M20A. Finally, while in vitro selection by Nef-specific CTL readily drives disruption of the nef reading frame, the addition of Gag- or RT-specific CTL markedly limits such escape. These data indicate that MHC-I down-regulation is an important function favoring Nef maintenance due to a net selective advantage in the setting of the general CTL response.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Cell Line
  • Clone Cells
  • Coculture Techniques
  • Down-Regulation / immunology
  • Gene Products, gag / genetics
  • Gene Products, gag / immunology
  • Gene Products, nef / biosynthesis*
  • Gene Products, nef / genetics
  • Gene Products, nef / immunology
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • HIV-1 / metabolism*
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Molecular Sequence Data
  • Point Mutation
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / virology*
  • Virus Replication / immunology*
  • nef Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, gag
  • Gene Products, nef
  • Histocompatibility Antigens Class I
  • nef Gene Products, Human Immunodeficiency Virus